Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Inventory: 2011-2025

Historic Inventory for Niagen Bioscience (NAGE) over the last 12 years, with Sep 2025 value amounting to $18.8 million.

  • Niagen Bioscience's Inventory rose 78.22% to $18.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.8 million, marking a year-over-year increase of 78.22%. This contributed to the annual value of $9.2 million for FY2024, which is 36.72% down from last year.
  • Per Niagen Bioscience's latest filing, its Inventory stood at $18.8 million for Q3 2025, which was up 30.44% from $14.4 million recorded in Q2 2025.
  • Niagen Bioscience's Inventory's 5-year high stood at $18.8 million during Q3 2025, with a 5-year trough of $9.2 million in Q4 2024.
  • In the last 3 years, Niagen Bioscience's Inventory had a median value of $12.0 million in 2023 and averaged $12.7 million.
  • Its Inventory has fluctuated over the past 5 years, first plummeted by 36.72% in 2024, then surged by 78.22% in 2025.
  • Niagen Bioscience's Inventory (Quarterly) stood at $13.6 million in 2021, then increased by 7.91% to $14.7 million in 2022, then dropped by 1.04% to $14.5 million in 2023, then crashed by 36.72% to $9.2 million in 2024, then spiked by 78.22% to $18.8 million in 2025.
  • Its last three reported values are $18.8 million in Q3 2025, $14.4 million for Q2 2025, and $11.2 million during Q1 2025.